Paper Details
- Home
- Paper Details
Original Abstract of the Article :
The cognitive adverse effects (AEs) of electroconvulsive therapy (ECT) limit the wider use of the treatment. These AEs can be attenuated by changing the way ECT is administered; however, such changes may reduce the response rate, the speed of response, or both. A recent systematic review and meta-an...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.4088/JCP.22f14668
データ提供：米国国立医学図書館（NLM）
Reconsidering the Benefits of Pharmacological Interventions for ECT-Induced Cognitive AEs
The [electroconvulsive therapy (ECT)] field is constantly striving to optimize this treatment modality, seeking to minimize [cognitive adverse effects (AEs)] while maximizing therapeutic benefits. This review critically examines the evidence for pharmacological interventions aimed at attenuating ECT-induced cognitive AEs. The authors analyzed data from [randomized controlled trials (RCTs)] investigating various interventions, including [acetylcholinesterase inhibitors, ketamine, memantine, liothyronine, anti-inflammatory treatments, and opioid receptor antagonists]. Their findings suggest potential benefits for some interventions, particularly [acetylcholinesterase inhibitors, ketamine, memantine, and liothyronine], in improving cognitive function. This review provides a valuable framework for understanding the potential benefits and limitations of pharmacological interventions for mitigating ECT-induced cognitive AEs.
Navigating the Complexities of ECT Treatment
The review's findings underscore the importance of a multi-faceted approach to ECT treatment. The authors' analysis highlights the need for careful consideration of the potential benefits and risks associated with different pharmacological interventions. It emphasizes the importance of individualized care, tailored to the specific needs and goals of each patient. The review also underscores the importance of further research to develop more effective strategies for minimizing ECT-induced cognitive AEs and maximizing therapeutic outcomes.
Balancing Benefits and Risks: A Desert Oasis in ECT Treatment
ECT treatment can feel like navigating a desert of uncertainty, with the potential for both therapeutic benefits and cognitive challenges. This review provides valuable insights into the potential role of pharmacological interventions in mitigating cognitive AEs. The authors' analysis suggests that carefully selected interventions, such as [acetylcholinesterase inhibitors, ketamine, memantine, and liothyronine], may help patients navigate the desert of ECT treatment and find a more comfortable oasis. I encourage individuals considering ECT to consult with their healthcare providers to discuss the potential benefits and risks of treatment and to explore options for minimizing cognitive AEs.
Dr.Camel's Conclusion
This review provides a critical analysis of the evidence for pharmacological interventions for attenuating ECT-induced cognitive AEs. The authors' insights are invaluable for informing clinical practice and guiding future research in this complex and rapidly evolving field. I encourage individuals considering ECT to discuss their concerns with their healthcare providers and to work together to develop a comprehensive treatment plan that addresses both therapeutic needs and potential cognitive side effects.
Date :
- Date Completed 2022-10-07
- Date Revised 2022-11-01
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.